Psoriasis is a chronic immune-mediated dermatosis with systemic implications, including psoriatic arthritis and cardiometabolic risk. At SMSL, we provide inflammatory markers (CRP/ESR), hepatitis/HIV/TB screens for biologic eligibility, lipid, glucose, liver and renal panels for comorbidity management, targeted microbiology/molecular tests to rule out mimics or superinfection, and therapeutic drug monitoring (TDM) for biologics where appropriate. Assays run on ELISA/CLIA, molecular, microbiology, and chemistry platforms from our expanded global partners to support precise, safe, and personalized management.